Banked acute-phase and convalescent-phase serum samples from a previous study of respiratory illness in university students were examined for significant (у2-fold) increases in ELISA titers of IgA and IgG antibody to Bordetella pertussis filamentous hemagglutinin, pertactin, and fimbriae-2 and у4-fold titer increases to agglutinogens by agglutination. ELISA titers of antibody to pertussis toxin could not be determined because of technical problems. Chlamydia pneumoniae infections were diagnosed by culture or by a у4-fold increase in immunofluorescence assay titer or a single high titer (у512). Mycoplasma pneumoniae, influenza A and B, adenovirus, and respiratory syncytial virus infections were diagnosed by у4-fold increases in complement fixation titer or a single high titer (у64). There were 319 subjects with cough of у5 days' duration, and of these, 47 (15%) had significant increases in antibody to B. pertussis antigens; 26 (8%) had significant increases to fimbriae-2 or agglutinogens, indicative of B. pertussis infection, and 2 (1%) had evidence of non-B. pertussis bordetella infections. Seventeen (36%) had evidence of mixed infections or cross-reacting antibodies (influenza B infections, 5; adenovirus infections, 4; influenza A infections, 3; C. pneumoniae infections, 3; and M. pneumoniae infections, 2). Our findings suggest that bordetella infections are common in young adults with cough illnesses (incidence, 9%), and a surprising number of these are mixed infections with other respiratory pathogens.
During the past decade, there has been an increased awareness of Bordetella pertussis infections in adolescents and adults [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Specific studies in adolescent and adult populations have indicated that 12%-32% of illnesses with prolonged cough are due to B. pertussis infections [1-3, 5, 6, 8-11] . The breakthrough that enabled the diagnosis of B. pertussis infection in these studies was the development and standardization of the quantitative B. pertussis ELISA, which employs pertussis toxin (PT) and other B. pertussis antigens.
To date, few studies have examined both B. pertussis and other possible respiratory pathogens in the same investigation. In a previous study, members of our group found evidence of both Mycoplasma pneumoniae and B. pertussis in 3 subjects, which suggested mixed infection or perhaps cross-reacting antibodies [1] . In another recent study we looked at single antibody values to B. pertussis antigens as well as M. pneumoniae, Chlamydia pneumoniae, and adenovirus in soldiers with cough illnesses [14] . Older literature suggests that mixed adenovirus and B. pertussis infections have not been uncommon [21] [22] , and case reports suggest that these coinfections may lead to more severe disease in young infants [23, 24] . In this present investigation we looked for bordetella infections as well as viral, mycoplasma, and chlamydia infections in 319 university students with cough illnesses of у5 days' duration.
Methods

Subjects and procedures.
This study used banked acute-phase and convalescent-phase serum samples and clinical and laboratory data obtained during a prospective study of acute respiratory infections among students at the University of Washington (Seattle), described elsewhere [25] . That study enrolled students who presented to the primary care clinic of the student health center with symptoms of an acute respiratory infection that had been judged by a health care provider to be more severe than a common cold. Clinical information was either recorded by the study nurse at the time of enrollment or abstracted later from each patient's medical chart. For the current study, we selected a subgroup of subjects who reported cough of у5 days' duration at the time of enrollment.
Study procedures included the collection of 2 swab specimens from the posterior oropharynx for Chlamydia isolation and collection of a serum sample at enrollment and 3-4 weeks later.
Laboratory procedures.
The oropharyngeal swab specimens were tested for the presence of viable chlamydiae by inoculation in HL cell cultures [25] . Inclusions were stained with Chlamydia genus-specific monoclonal antibody conjugated to fluorescein and were identified as C. pneumoniae with specific monoclonal antibody in indirect fluorescent staining. Serological testing for C. pneumoniae, M. pneumoniae, influenza A and B, adenovirus, and respiratory syncytial virus was also performed. A microimmunofluorescence assay was used to detect IgG and IgM antibodies to C. pneumoniae. Evidence of acute C. pneumoniae infection was defined by a у4-fold increase in titer of the IgG or IgM fraction or by a single IgM titer у16 or IgG titer у512. CF testing was used to detect antibodies to M. pneumoniae, influenza viruses A and B, adenovirus, and respiratory syncytial virus. CF titers that showed a у4-fold increase or a single titer у64 were considered evidence of acute infection with a specific organism. IgG and IgA antibodies to B. pertussis antigens were detected by ELISA as previously described, except that specific ELISA units (EU/mL) were determined by means of a reference-line computer program rather than a parallel-line program [1, 16, 17, [26] [27] [28] . The following B. pertussis antigens were used: PT, filamentous hemagglutinin (FHA), pertactin, and fimbriae-2. ELISA unitage was determined with use of the United States reference pertussis antiserum (human), lots 3 and 4 (US Food and Drug Administration) [28] . The limit of quantitation for IgA and IgG antibody to each of the 4 antigens was estimated to be 6 EU/mL. Validation of the assay is presented in detail by Hodder et al. in this issue [17] . On the basis of the validation data, a у2-fold increase in either IgA or IgG antibody to у1 antigens, with a second serum sample with a titer у20 EU/mL, was considered evidence of infection.
Our initial ELISA studies found that titers of antibody to PT could not be determined. The sera responded as if they had been heat-inactivated [29] . These sera were 110 years old, but there was no history of heat inactivation. Heat-inactivated sera yield false optical density readings in the PT ELISA but do not give false data with the other antigens. Since titers of both IgA and IgG antibodies to PT could not be reliably determined, these ELISA results have been omitted from the present study.
B. pertussis agglutinin titers were determined with use of BP 460 as the antigen; a у4-fold titer increase, with a convalescent-phase titer у32, was considered evidence of infection [27] .
Results
Demographics. There were 667 students enrolled in the acute respiratory disease study; 334 reported cough of у5 days' duration, and paired serum specimens were available for testing from 319 of the 334. Clinical and laboratory data from these 319 subjects are analyzed in this report. In this group, there were 179 women (56%). The following age groups were noted: aged 17-19 years, 22%; aged 20-22 years, 39%; aged 23-25 years, 14%; and aged у26 years, 25%. The mean duration of cough at enrollment was 13.4 days (99% CI, 12.3-14.4 days) .
B. pertussis serology. Forty-seven (15%) of the 319 study subjects with cough of у5 days' duration had a significant increase in ELISA titer of IgA or IgG to у1 B. pertussis antigens or a significant agglutinin response. The antibody response patterns in these 47 subjects are presented in table 1. Of the 47 subjects with a significant titer increase, 15 (32%) had a response in у2 and 10 (21%) had a response in у3 tests. Overall, IgA responses were more common (68%) than IgG responses (57%). Responses to fimbriae-2 and pertactin (52% and 51%, respectively) were more common than responses to FHA or agglutinogens (32% and 4%, respectively).
Overall, 26 subjects (8%) had a significant increase in titer of IgA or IgG to fimbriae-2 and/or a significant agglutinin response, with or without a response to FHA or pertactin, which suggested B. pertussis-specific infection. Five subjects had a significant increase in IgA or IgG to only FHA, and 13 had a significant increase in IgA or IgG to only pertactin. Two a Significant increase was defined as a у2-fold increase in titer of IgA or IgG ELISA antibody to filamentous hemagglutinin, pertactin, and fimbriae-2, with the convalescent-phase value у20 EU/mL, or a у4-fold increase in agglutinin titer, with the convalescent-phase value у32.
subjects had a significant increase in IgA or IgG to both FHA and pertactin, without an increase to either fimbriae-2 or agglutinogens, which suggested a non-B. pertussis bordetella infection. Mixed infections. Seventeen (36%) of the 47 subjects with an increase in titer of antibody to у1 B. pertussis antigens had evidence of infection with another agent as well: 5 were infected with influenza B, 4 with adenovirus, 3 with influenza A, 3 with C. pneumoniae, and 2 with M. pneumoniae. The Bordetella species-antibody response patterns of these 17 subjects are presented in relation to other specific infectious agents in table 2. Five subjects had an antibody titer increase in у2 tests, and 8 had a response to fimbriae-2.
Clinical findings. Table 3 compares the signs, symptoms, and laboratory findings at the time of enrollment for the 47 subjects with significant increases in titer of antibody to B. pertussis antigens and for the 272 subjects without such titer increases. As can be seen, there were no major differences in clinical findings for subjects with or without serological evidence of infection. Similarly, there were no major differences between the clinical findings for subjects with significant increases in titer of antibody to only the B. pertussis antigens and those for subjects with mixed infections.
Discussion
It is unfortunate that titers of PT antibodies could not be determined in this study, because these antibodies are B. pertussis-specific, whereas antibodies to FHA and pertactin crossreact with Bordetella parapertussis and Bordetella bronchiseptica [14, 30] . In a study of 23 children with culture-confirmed B. parapertussis infection [23] , it was found that 19 had a significant IgA or IgG ELISA antibody response to PT, FHA, pertactin, or fimbriae-2. Of the 19 subjects who had titer increases, 100% had an increase in antibody to FHA; 79%, to pertactin; 42%, to fimbriae-2; and 16%, to PT. Since B. parapertussis does not liberate PT, it was assumed in that study that the 3 subjects with PT antibody responses had mixed infections with both B. pertussis and B. parapertussis. However, the finding of FHA and pertactin antibody responses without PT responses indicated that antibody titer increases against these 2 antigens are unreliable for the diagnosis of B. pertussis infections.
In addition to B. parapertussis and B. bronchiseptica, which cause cough illnesses in humans, it has recently been reported that Bordetella holmesii can cause a pertussis-like illness [31] . Although specific serological data are not available, it is likely that infection with B. holmesii also elicits an antibody response to B. pertussis FHA and perhaps to B. pertussis pertactin.
In a recent study in which high single antibody values were evaluated, members of our group found that a significant number of subjects with cough had only high FHA antibody values but not high PT, pertactin, or agglutinin antibody values [14] . This observation suggested that these illnesses were not due to B. pertussis or other Bordetella species but to an unrecognized agent, or involved cross-reacting antibodies or perhaps polyclonal responses. The analysis in that study found a relationship between both M. pneumoniae and C. pneumoniae and high FHA values. In the present investigation, only a modest number of subjects had antibody responses to these 2 agents and B. pertussis antigens, but the 2 subjects with M. pneumoniae antibody had a significant IgA response to FHA.
In the absence of the ability to measure antibody to PT, the best marker for B. pertussis-specific infection is an increase in titer of antibody to fimbriae-2 or an agglutinin response. Overall, 26 (8%) of the 319 subjects with cough illness had a significant increase in titer of antibody to fimbriae-2 or an agglutinin response, which indicated B. pertussis infection. Two subjects had increases in titer of antibody to pertactin and FHA without a fimbriae-2 or agglutinin increase, which suggested a non-B. pertussis bordetella infection. Therefore, in spite of the lack of PT antibody data, our findings are consistent with other recent studies indicating that bordetella infections are the cause of a substantial number of illnesses with prolonged coughs in adolescents and adults [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Clinical findings (table 3) were not useful in distinguishing subjects with increases in titer of antibody to B. pertussis antigens from those without such increases.
Of the 47 infections identified by increases in titer of antibody to B. pertussis antigens, a surprising number (36%) were evidently mixed infections with other respiratory agents. The diversity of the other respiratory agents makes cross-reacting an-
